Center on Health Equity & Access
Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Biosimilars Cardiorenalmetabolic Dermatology Hematology Hepatology Immunology Infectious Disease Mental Health Neurology Obesity Oncology Ophthalmology Pulmonology Rare Disease Respiratory Rheumatology Women's Health

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars Center on Health Equity & Access Digital Health Formulary Gene Therapy Guidelines Health Care Administration Health Care Cost Health Care Delivery Insurance Policy Population Health Product Approvals and Launches Technology Value-Based Care

All Coverage Event Coverage Interviews News

AJMC Journals Anniversary Author Forms Authors Nominate a Rising Leader Submit a Manuscript

EHA 2024: Highlights in Multiple Myeloma

home / post-conference-perspectives / eha-2024-highlights-in-multiple-myeloma

Joseph Mikhael, MD, shares insights surrounding key updates in multiple myeloma management as presented at EHA 2024.

Latest Trends and Innovations in Multiple Myeloma Management at EHA 2024

EP. 1: Latest Trends and Innovations in Multiple Myeloma Management at EHA 2024

Joseph Mikhael, MD, discusses the latest trends and innovations regarding multiple myeloma management.

Watch

EHA 2024 Insights: Impact of the IMROZ Study on Newly Diagnosed Multiple Myeloma

EP. 2: EHA 2024 Insights: Impact of the IMROZ Study on Newly Diagnosed Multiple Myeloma

Joseph Mikhael, MD, discusses the latest trends and innovations regarding multiple myeloma management.

Watch

PERSEUS Trial Findings at EHA 2024

EP. 3: PERSEUS Trial Findings at EHA 2024

Joseph Mikhael, MD, discusses the PERSEUS trial findings presented at EHA 2024.

Watch

Joseph Mikhael, MD, an expert on multiple myeloma

EP. 4: Treatment in Early Relapse Multiple Myeloma: Takeaways from EHA 2024

Joseph Mikhael, MD

Dr. Mikhael discusses treatment in early relapse of multiple myeloma.

Watch

Joseph Mikhael, MD, an expert on multiple myeloma

EP. 5: EHA 2024: Teclistimab in High-Risk Relapsed/Refractory Multiple Myeloma

Joseph Mikhael, MD

Dr. Mikhael discusses the safety and usefulness of tesclistimab in patients with high-risk refractory multiple myeloma.

Watch

Joseph Mikhael, MD, an expert on multiple myeloma

EP. 6: EHA 2024 Highlights: Overcoming Challenges with Bispecific Antibodies in RRMM

Joseph Mikhael, MD

Dr. Mikhael outlines the significant hurdles in bispecific antibody therapy, as presented at the European Hematology Association's 2024 conference.

Watch

Joseph Mikhael, MD, an expert on multiple myeloma

EP. 7: Beyond EHA 2024: Promising Research in Multiple Myeloma to Watch

Joseph Mikhael, MD

Dr. Mikhael discusses EHA 2024 data he found particularly noteworthy to share with colleagues.

Watch

Editorial Boards

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences
AJMC®
All rights reserved.